Could MRONJ Be Related to Osimertinib Monotherapy in Lung Cancer Patients after Denosumab Suspension?

Could MRONJ Be Related to Osimertinib Monotherapy in Lung Cancer Patients after Denosumab Suspension?

Background: Medication-related osteonecrosis of the jaws is the most frequent complication in patients treated or in therapy with antiresorptive/antiangiogenetic drugs. The list of medications possibly related to MRONJ onset is constantly growing; we aimed to report on a third-generation epidermal g...

Full description

Bibliographic Details
Main Authors: Marta Forte, Antonio d’Amati, Luisa Limongelli, Massimo Corsalini, Gianfranco Favia, Giuseppe Ingravallo, Giuseppe Barile, Saverio Capodiferro
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Healthcare
Subjects:
MRONJ
Denosumab
Osimertinib
lung cancer
prevention
jaws
Online Access:https://www.mdpi.com/2227-9032/12/4/457

Internet

https://www.mdpi.com/2227-9032/12/4/457

Similar Items